Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

143 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.
Duffy MJ, Maguire TM, McDermott EW, O'Higgins N. Duffy MJ, et al. Among authors: mcdermott ew. J Surg Oncol. 1999 Jun;71(2):130-5. doi: 10.1002/(sici)1096-9098(199906)71:2<130::aid-jso14>;2-9. J Surg Oncol. 1999. PMID: 10389872 Review.
Tamoxifen as the primary treatment in elderly patients with breast cancer.
Hooper SB, Hill AD, Kennedy S, Dijkstra B, Kelly LM, McDermott EW, O'Higgins N. Hooper SB, et al. Among authors: mcdermott ew. Ir J Med Sci. 2002 Jan-Mar;171(1):28-30. doi: 10.1007/BF03168937. Ir J Med Sci. 2002. PMID: 11993590
Role of bone scan in addition to CT in patients with breast cancer selected for systemic staging.
McCartan DP, Prichard RS, MacDermott RJ, Rothwell J, Geraghty J, Evoy D, Quinn CM, Skehan SJ, O'Doherty A, McDermott EW. McCartan DP, et al. Among authors: mcdermott ew. Br J Surg. 2016 Jun;103(7):839-44. doi: 10.1002/bjs.10124. Epub 2016 Mar 23. Br J Surg. 2016. PMID: 27004443
ADAM-17: a novel therapeutic target for triple negative breast cancer.
McGowan PM, Mullooly M, Caiazza F, Sukor S, Madden SF, Maguire AA, Pierce A, McDermott EW, Crown J, O'Donovan N, Duffy MJ. McGowan PM, et al. Among authors: mcdermott ew. Ann Oncol. 2013 Feb;24(2):362-369. doi: 10.1093/annonc/mds279. Epub 2012 Sep 11. Ann Oncol. 2013. PMID: 22967992
mTOR in breast cancer: differential expression in triple-negative and non-triple-negative tumors.
Walsh S, Flanagan L, Quinn C, Evoy D, McDermott EW, Pierce A, Duffy MJ. Walsh S, et al. Among authors: mcdermott ew. Breast. 2012 Apr;21(2):178-82. doi: 10.1016/j.breast.2011.09.008. Epub 2011 Sep 29. Breast. 2012. PMID: 21963359
Src: a potential target for the treatment of triple-negative breast cancer.
Tryfonopoulos D, Walsh S, Collins DM, Flanagan L, Quinn C, Corkery B, McDermott EW, Evoy D, Pierce A, O'Donovan N, Crown J, Duffy MJ. Tryfonopoulos D, et al. Among authors: mcdermott ew. Ann Oncol. 2011 Oct;22(10):2234-40. doi: 10.1093/annonc/mdq757. Epub 2011 Feb 28. Ann Oncol. 2011. PMID: 21357651
Functional and prognostic relevance of the homeobox protein MSX2 in malignant melanoma.
Gremel G, Ryan D, Rafferty M, Lanigan F, Hegarty S, Lavelle M, Murphy I, Unwin L, Joyce C, Faller W, McDermott EW, Sheahan K, Ponten F, Gallagher WM. Gremel G, et al. Among authors: mcdermott ew. Br J Cancer. 2011 Aug 9;105(4):565-74. doi: 10.1038/bjc.2011.249. Epub 2011 Jul 5. Br J Cancer. 2011. PMID: 21730974 Free PMC article.
Clinicopathologic features of sentinel node metastases predictive of positive axillary clearance in grade 1 invasive breast carcinoma.
Hayes B, McCormack O, Quinn CM, McDermott EW, Evoy D. Hayes B, et al. Among authors: mcdermott ew. Ir J Med Sci. 2009 Dec;178(4):447-51. doi: 10.1007/s11845-009-0350-4. Ir J Med Sci. 2009. PMID: 19430865
Meta-analysis of sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with initial biopsy-proven node-positive breast cancer.
Tee SR, Devane LA, Evoy D, Rothwell J, Geraghty J, Prichard RS, McDermott EW. Tee SR, et al. Among authors: mcdermott ew. Br J Surg. 2018 Nov;105(12):1541-1552. doi: 10.1002/bjs.10986. Br J Surg. 2018. PMID: 30311642
A Positive Node on Ultrasound-Guided Fine Needle Aspiration Predicts Higher Nodal Burden Than a Positive Sentinel Lymph Node Biopsy in Breast Carcinoma.
Boland MR, Ni Cearbhaill R, Fitzpatrick K, Walsh SM, Evoy D, Geraghty J, Rothwell J, McNally S, O'Doherty A, Quinn CM, McDermott EW, Prichard RS. Boland MR, et al. Among authors: mcdermott ew. World J Surg. 2016 Sep;40(9):2157-62. doi: 10.1007/s00268-016-3557-3. World J Surg. 2016. PMID: 27206399
143 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page